| Loss of Asxl1 leads to myelodysplastic syndrome–like disease in mice J Wang, Z Li, Y He, F Pan, S Chen, S Rhodes, L Nguyen, J Yuan, L Jiang, ... Blood, The Journal of the American Society of Hematology 123 (4), 541-553, 2014 | 180 | 2014 |
| RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells D Guallar, X Bi, JA Pardavila, X Huang, C Saenz, X Shi, H Zhou, F Faiola, ... Nature genetics 50 (3), 443-451, 2018 | 134 | 2018 |
| Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells F Pan, TS Wingo, Z Zhao, R Gao, H Makishima, G Qu, L Lin, M Yu, ... Nature communications 8 (1), 15102, 2017 | 115 | 2017 |
| Combined loss of Tet1 and Tet2 promotes B cell, but not myeloid malignancies, in mice Z Zhao, L Chen, MM Dawlaty, F Pan, O Weeks, Y Zhou, Z Cao, H Shi, ... Cell Reports 13 (8), 1692-1704, 2015 | 113 | 2015 |
| Ten-eleven translocation 2 interacts with forkhead box O3 and regulates adult neurogenesis X Li, B Yao, L Chen, Y Kang, Y Li, Y Cheng, L Li, L Lin, Z Wang, M Wang, ... Nature communications 8 (1), 15903, 2017 | 97 | 2017 |
| The TET2 interactors and their links to hematological malignancies F Pan, O Weeks, FC Yang, M Xu IUBMB life 67 (6), 438-445, 2015 | 37 | 2015 |
| High-efficiency CRISPR induction of t (9; 11) chromosomal translocations and acute leukemias in human blood stem cells J Jeong, A Jager, P Domizi, M Pavel-Dinu, L Gojenola, M Iwasaki, ... Blood advances 3 (19), 2825-2835, 2019 | 33 | 2019 |
| The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells Z Zhao, S Chen, X Zhu, F Pan, R Li, Y Zhou, W Yuan, H Ni, FC Yang, ... Leukemia 30 (8), 1784-1788, 2016 | 31 | 2016 |
| Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ ve AML H Sayar, Y Liu, R Gao, MA Zaid, LD Cripe, J Weisenbach, KJ Sargent, ... Oncotarget 9 (5), 5703, 2018 | 3 | 2018 |
| Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells F Pan, M Iwasaki, W Wu, Y Jiang, X Yang, L Zhu, Z Zhao, ML Cleary Blood Advances 7 (11), 2504-2519, 2023 | 2 | 2023 |
| TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies EF Greenberg, CM Hirsch, F Pan, BK Jha, Y Guan, V Visconte, D You, ... Blood 130, 1668, 2017 | 1 | 2017 |
| Genome editing–induced t (4; 11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion F Pan, J Sarno, J Jeong, X Yang, A Jager, TA Gruber, KL Davis, ... The Journal of Clinical Investigation 134 (1), 2024 | | 2024 |
| Three-dimensional chromatin landscapes in MLLr AML P Sui, P Zhang, F Pan bioRxiv, 2023.11. 02.565383, 2023 | | 2023 |
| Demonstration That Loss of TET2 Impairs DNA Mismatch Repair Resulting in Clonally Restricted Genomic Instability D Jiang, F Pan, Y Guan, X Gu, N Kawashima, DJ Singh, D Dima, G Qu, ... Blood 140 (Supplement 1), 1989-1990, 2022 | | 2022 |
| TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins A Kishtagari, Y Guan, CM Kerr, H Awada, J Durrani, EF Greenberg, X Gu, ... Blood 134, 1200, 2019 | | 2019 |
| " Ribopepzymes" are probably a link from ribozymes to protein enzymes Y Sheng, D Jiang, Z Zeng, F Pan, J Zhang Nature Precedings, 1-1, 2008 | | 2008 |
